Serious Gaming for Nausea and Vomiting
Trial Summary
What is the purpose of this trial?
The purpose of this study is to examine the effectiveness of a technology-based intervention for managing nausea and vomiting in older adults with cancer. Participants will be randomized to either an intervention or control group. Outcomes such as symptom severity, quality of life, and resource use will be examined.
Do I need to stop my current medications to join the trial?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment eSSET-CINV for nausea and vomiting?
Is the serious game treatment for nausea and vomiting safe for humans?
There is no specific safety data available for the serious game treatment for nausea and vomiting, but health-based games are generally considered low cost and can be deployed safely at the point of care. However, a robust evidence base for their safety and efficacy as clinical interventions is still lacking.678910
How is the eSSET-CINV treatment different from other treatments for nausea and vomiting?
The eSSET-CINV treatment is unique because it uses a serious game to help older adults manage chemotherapy-induced nausea and vomiting (CINV). This approach focuses on teaching and reinforcing self-management strategies through an interactive and engaging platform, which is different from traditional medication-based treatments.123511
Research Team
Victoria Loerzel, PhD
Principal Investigator
University of Central Florida
Eligibility Criteria
This trial is for people aged 60 or older who have recently been diagnosed with cancer and are starting chemotherapy that's known to cause moderate to severe nausea and vomiting. They must be on a treatment cycle of 2, 3, or 4 weeks, speak English fluently, and have access to a telephone.Inclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Chemotherapy Treatment
Participants receive chemotherapy treatment cycles, with the intervention group using a serious game for self-management of nausea and vomiting
Follow-up
Participants are monitored for healthcare resource use, CINV severity, self-management behaviors, symptom severity, cognitive representation, and health-related quality of life
Treatment Details
Interventions
- eSSET-CINV (Behavioral Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Central Florida
Lead Sponsor
Dr. Michael Pape
University of Central Florida
Chief Executive Officer since 2015
PhD in Biochemistry from Purdue University, MBA from the University of Chicago Booth School of Business
Dr. James J. Hickman
University of Central Florida
Chief Medical Officer since 2020
MD from University of Central Florida College of Medicine
National Institute of Nursing Research (NINR)
Collaborator
Dr. Jessica Gill
National Institute of Nursing Research (NINR)
Chief Medical Officer since 2023
PhD in Nursing from Johns Hopkins University
Dr. Shannon Zenk
National Institute of Nursing Research (NINR)
Chief Executive Officer since 2020
PhD in Urban Planning and Policy Development from Rutgers University
University of Miami
Collaborator
Sylvia Daunert
University of Miami
Chief Executive Officer since 2011
PhD in Biochemistry and Molecular Biology, University of Kentucky
Bahar Motlagh
University of Miami
Chief Medical Officer since 2021
PhD in Biomedical Engineering, Ecole Polytechnique Montreal
Orlando Health, Inc.
Collaborator